Sugi Predict

Sugi Predict / Compounds / SCHEMBL14717465

SCHEMBL14717465

SCHEMBL14717465

O=C(O)c1ccccc1C1CCOC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ F2 P00734 1/20 0.40
▸ PLG P00747 1/20 0.40
▸ PLAU P00749 1/20 0.40
▸ PLAT P00750 1/20 0.40
▸ KLK1 P06870 1/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ HMGB1 P09429 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ CA7 P43166 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730750 0.90 CYP2C9 (0.49) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL29782303 0.86 CYP2C9 (0.51) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL633935 0.85 ADRA1A (0.44) ALDH1A1F2PLGPLAUPLAT
SCHEMBL4079916 0.82 CYP2C9 (0.51) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL27895826 0.81 RBP4 (0.37) CYP2C9F2PLGPLAUPLAT
SCHEMBL15575196 0.80 ALOX15 (0.40) CYP2C9ALDH1A1ALOX15F2PLG
SCHEMBL30175300 0.80 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL10457353 0.80 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL4109572 0.80 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15KDM4ECA12
SCHEMBL29964414 0.78 KDM4E (0.42) CYP2C9ALDH1A1ALOX15F2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023065683-A1 NOVEL DEUTERATED PURINE NUCLEOSIDE COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION THEREOF, AND APPLICATION THEREOF 广州谷森制药有限公司 2023-04-27 — — WO disclosed
CN-114727991-A Arylmethylene heterocyclic compounds as Kv1.3 potassium SHAKER channel blockers D·E·萧尔研究有限责任公司 2022-07-08 — — CN disclosed
CN-114126614-A Heterocyclic compounds as PRMT5 inhibitors 安杰斯制药公司 2022-03-01 — — CN disclosed
US-20160051531-A1 SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN INC (US) 2016-02-25 — — US disclosed
US-9067905-B2 Sulphone compounds and methods of making and using same ZAFGEN, INC. (US) 2015-06-30 — — US disclosed
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160051531-A1 SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME METAP2, DNPEP, STS CYP2C9 568/4885ALDH1A1 360/4885ALOX15 817/4885
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same METAP2, DNPEP, STS CYP2C9 568/4885ALDH1A1 360/4885ALOX15 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.